We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.50 | -0.04% | 1,334.50 | 1,334.50 | 1,335.50 | 1,337.50 | 1,333.00 | 1,335.00 | 267,497 | 08:41:03 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1889 | 11.22 | 55.34B |
Date | Subject | Author | Discuss |
---|---|---|---|
15/2/2023 12:08 | This should be a Federal Case (not state by state). | tradermichael | |
15/2/2023 11:44 | I think in thu the judge announces whether GSK has a case to answer and whether or.not the 3000 claimants can sue , if yes then trial date will be set . That's my understanding | alibizzle | |
15/2/2023 11:29 | In GSK third quarter press release its a bit unclear: " In the California Zantac litigation Cases JCCP 5150 (JCCP), the Court will hold a Sargon hearing on 25 January 2023 regarding the admissibility of expert witnesses, including general causation expert witnesses, for the first bellwether trials. The first bellwether trial is expected to start on 13 February 2023 in the California JCCP. " It says started on MONDAY - but nothing about ending on THURSDAY | netcurtains | |
15/2/2023 11:25 | Can't be more than a preliminary hearing then? | tradermichael | |
15/2/2023 10:48 | Ah. Yep, so that is what I first said. "we would probably know on Friday". Thanks. I thought I was going mad for a minute. | netcurtains | |
15/2/2023 10:07 | Netcurtains the case started Monday ( well technically last week ) and results due thu in America, Fri here , according to the times | alibizzle | |
15/2/2023 10:05 | The previous outcome is probably the best GSK could have hoped for given how comprehensively the judge in the case dismissed the plaintiffs’ arguments. Rejected in Florida, shot down by FDA, its hard to see how anything will get through this time. Elsewhere, failing clinical trials for new pipeline therapies is more of a risk... | tradermichael | |
15/2/2023 09:56 | Alibizzle: In all your previous posts you keep going on about some outcome on THUSDAY... Can you confirm what you meant... Your posts are really confusing. Sorry. One minute its Monday the next Thursday... | netcurtains | |
15/2/2023 09:53 | Alibizzle: So why did everyone start talking about thursday? Whats the big deal with thursday? | netcurtains | |
15/2/2023 09:28 | Case started on Monday | alibizzle | |
15/2/2023 07:52 | So how long did the Florida case last before it was thrown out? Do we know? Anyone? | netcurtains | |
15/2/2023 07:25 | Surely won't complete in a single day? | tradermichael | |
14/2/2023 15:34 | Market Jittery about Thursday.... Does anyone have an estimate on when we might have the decision? I suspect it will be after close. So we'll have some information by FRIDAY MORNING.... But its going to be an interesting ride over the next few days. | netcurtains | |
14/2/2023 09:00 | How many? 375,932.252 shares vesting...and there's more!! 375,932 for 2018 on basis of 2017 performance 237,385 for 2020 on basis of 125,482 as a deferred bonus!!! Nice little earner for bringing little value to shareholders. Over promoted because of her gender. Suitability for the role, questionable. | geckotheglorious | |
13/2/2023 11:52 | Cliffordnua - peddle off. Filtered | wsm812 | |
13/2/2023 09:58 | Ah ok fair enough . This is going to drag on , and the share price isn't going to go anywhere near £17 anytime soon | alibizzle | |
13/2/2023 08:45 | Alibizzle: But it can only be good news or neutral-ish. There can be no decision on outcome of case for months or years. So really, logically, it can only be good or neutral-ish. zho said "he agreed BUT".... There is no "but". Deciding to go ahead with case or not is a sperate issue to outcome of case. Obviously deciding there is a case to answer is not as good as dismissal but one would have to assume that is in the price (for the most part) - otherwise what was the point of the big fall? Surely the market has already assumed the case will go ahead? | netcurtains | |
13/2/2023 08:35 | Outcome on Thu is the point so news thus week . | alibizzle | |
13/2/2023 08:29 | zho: I dont see what point you're driving at? | netcurtains | |
13/2/2023 08:26 | >>If the case proceeds, I doubt whether we will see an outcome anytime soon!>> I would agree, but the Times article says: "But Zantac's ban in 2019, several years after GSK stopped selling it, has cast a long shadow. On Thursday, a judge in California is expected to rule on whether 3,000 cancer patients in the US have the right to sue GSK for damages that could run into the billions." | zho | |
13/2/2023 08:23 | If the case proceeds, I doubt whether we will see an outcome anytime soon! | tradermichael | |
13/2/2023 07:58 | Hope this is what happens , I think it's Thursday we will know the court case outcome isn't it? Still worried about California being hard on big pharma historically | alibizzle | |
12/2/2023 22:23 | Looks like mm’s backing GSK expecting a 8% rally as court case thrown out based also on US companies may be impacted if it’s not. GSK looking strong this week as RNS Wednesday is positive and rally continues .. Happy days ahead for GSK… | halfpenny |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions